Digital Event Horizon
NVIDIA and IQVIA Partner to Revolutionize Healthcare and Life Sciences with Domain-Expert Agentic AI
A groundbreaking collaboration between NVIDIA and IQVIA is set to transform the healthcare and life sciences industries by harnessing the power of agentic AI. This innovative partnership will leverage NVIDIA's cutting-edge technology to enable domain-expert AI models that can accelerate complex workflows in drug research and development, evidence management, and commercialization.
NVIDIA and IQVIA announce historic partnership to revolutionize research, development, and commercialization in healthcare and life sciences. IQVIA will leverage NVIDIA's AI Foundry platform to build custom foundation models and agentic AI workflows for accelerating research and clinical development. The partnership aims to accelerate innovation and improve patient outcomes by unlocking the full potential of AI in complex workflows. NVIDIA's technology, including Llama Nemotron and Cosmos Nemotron model families, will be used to build language and multimodal foundational models that power IQVIA AI agents. The use of agentic AI capabilities will enable IQVIA to automate complex tasks, such as document generation and patient recruitment, for healthcare professionals to focus on strategic decision-making and human interaction.
January 13, 2025, marked a significant milestone in the history of healthcare and life sciences as NVIDIA and IQVIA announced a historic partnership that will revolutionize the way research, development, and commercialization are conducted. This collaboration aims to accelerate innovation by harnessing the power of agentic AI, which is designed to work alongside humans to achieve complex tasks.
IQVIA, the world's leading provider of clinical research services, commercial insights, and healthcare intelligence, has long been at the forefront of the industry. With its unparalleled information assets, analytics, and domain expertise – known as IQVIA Connected Intelligence – IQVIA has established itself as a trusted partner for pharmaceutical, biotech, and medical device companies.
The partnership between NVIDIA and IQVIA will see the latter leveraging the NVIDIA AI Foundry platform to build custom foundation models and agentic AI workflows that can accelerate research, clinical development, and access to new treatments. This is made possible by the use of NVIDIA's cutting-edge technology, including the Llama Nemotron and Cosmos Nemotron model families; NVIDIA AI Blueprint reference workflows; the NVIDIA NeMo platform for developing custom generative AI; and dedicated capacity on NVIDIA DGX Cloud.
The healthcare and life sciences industry generates more information than any other industry in the world, making up 30% of the world's data volume. IQVIA plans to use its unparalleled information assets, analytics, and domain expertise with the NVIDIA AI Foundry service to build language and multimodal foundational models that will power a collection of customized IQVIA AI agents.
These agents are anticipated to be available in predefined workflows, or blueprints, that would accomplish a specific task. This partnership aims to accelerate the innovation cycle of IQVIA Healthcare-grade AI. IQVIA has been leading in the responsible use of AI, ensuring that its AI-powered capabilities are grounded in privacy, regulatory compliance, and patient safety.
One key opportunity area is in clinical development, when clinical trials are conducted for new drugs. The overall process takes about 11 years, on average, and each trial has a multitude of workflows that could be supported by AI agents. For example, just starting a clinical trial involves site selection, participant recruitment, regulatory submissions, and tight communication between study sites and their sponsors.
The use of NVIDIA's agentic AI capabilities will enable IQVIA to automate complex, time-consuming tasks, such as document generation and patient recruitment, allowing healthcare professionals to focus on strategic decision-making and human interaction. This is made possible by the integration of NVIDIA RAPIDS data science libraries, which accelerate the construction of knowledge graphs.
Furthermore, IQVIA's collection of models, AI agents, and reference workflows will be developed with the NVIDIA AI Foundry platform for building custom models, allowing IQVIA's thousands of pharmaceutical, biotech, and medical device customers to benefit from NVIDIA's agentic AI capabilities and IQVIA's technologies, life sciences information, and expertise.
The NVIDIA AI Blueprint for multimodal PDF data extraction can help IQVIA unlock the immense amount of healthcare text, graphs, charts, and tables stored in PDF files, bringing previously inaccessible information to train AI models and agents for domain-specific and even customer-specific applications. This is a testament to the versatility and power of NVIDIA's technology.
In conclusion, the partnership between NVIDIA and IQVIA represents a significant step forward in the use of agentic AI in healthcare and life sciences. By harnessing the power of NVIDIA's cutting-edge technology, IQVIA aims to accelerate innovation and improve patient outcomes by unlocking the full potential of AI in complex workflows. This collaboration will serve as a benchmark for future partnerships between industry leaders and innovative technology providers.
Related Information:
https://blogs.nvidia.com/blog/iqvia-agentic-ai-healthcare/
https://www.iqvia.com/newsroom/2025/01/iqvia-and-nvidia-collaborate-to-transform-healthcare-and-life-sciences
Published: Mon Jan 13 10:51:49 2025 by llama3.2 3B Q4_K_M
